These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23812935)

  • 1. Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.
    Lown RN; Tulpule S; Russell NH; Craddock CF; Roest R; Madrigal JA; Shaw BE
    Haematologica; 2013 Dec; 98(12):1956-63. PubMed ID: 23812935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34
    Stroncek DF; Shaw BE; Logan BR; Kiefer DM; Savani BN; Anderlini P; Bredeson CN; Hematti P; Ganguly S; Diaz MA; Abdel-Azim H; Ahmed I; Maharaj D; Seftel M; Beitinjaneh A; Seo S; Yared JA; Halter J; O'Donnell PV; Hale GA; DeFilipp Z; Lazarus H; Liesveld JL; Zhou Z; Munshi P; Olsson RF; Kasow KA; Szer J; Switzer GE; Chitphakdithai P; Shah N; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):175-184. PubMed ID: 28958894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.
    Panch SR; Logan B; Sees JA; Bo-Subait S; Savani B; Shah NN; Hsu JW; Switzer G; Lazarus HM; Anderlini P; Hematti P; Confer D; Pulsipher MA; Shaw BE; Stroncek DF
    Transplant Cell Ther; 2021 Jun; 27(6):503.e1-503.e8. PubMed ID: 33823169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing Ethical and Procedural Principles for Unrelated Allogeneic Hematopoietic Progenitor Cell Donation in a Changing Medical Environment.
    van Walraven SM; Egeland T; Borrill V; Nicoloso-de Faveri G; Rall G; Szer J;
    Biol Blood Marrow Transplant; 2018 May; 24(5):887-894. PubMed ID: 29410372
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow harvest from unrelated donors-up-to-date methodology.
    Pruszczyk K; Skwierawska K; Król M; Moskowicz A; Jabłoński D; Torosian T; Piotrowska I; Urbanowska E; Wiktor-Jędrzejczak W; Snarski E
    Eur J Haematol; 2017 Oct; 99(4):357-365. PubMed ID: 28719093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
    Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WMDA guidelines for subsequent donations following initial BM or PBSCs.
    Confer DL; Shaw BE; Pamphilon DH;
    Bone Marrow Transplant; 2011 Nov; 46(11):1409-12. PubMed ID: 21297674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
    Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):147-152. PubMed ID: 27717872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic Progenitor Cell Donation from Healthy Female Donors During Pregnancy: A Report of 10 Cases.
    El Fakih R; Alshammasi S; Alobaidi N; Alseraihy A; Kotb A; Shaheen M; Alfraih F; Aljurf M
    Transplant Cell Ther; 2022 Feb; 28(2):117.e1-117.e6. PubMed ID: 34813943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
    Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
    Bone Marrow Transplant; 1998 Jul; 22(1):73-8. PubMed ID: 9678799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe events in donors after allogeneic hematopoietic stem cell donation.
    Halter J; Kodera Y; Ispizua AU; Greinix HT; Schmitz N; Favre G; Baldomero H; Niederwieser D; Apperley JF; Gratwohl A
    Haematologica; 2009 Jan; 94(1):94-101. PubMed ID: 19059940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage.
    Lown RN; Marsh SG; Switzer GE; Latham KA; Madrigal JA; Shaw BE
    Bone Marrow Transplant; 2014 Apr; 49(4):525-31. PubMed ID: 24419516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
    Gordon SV; Nivison-Smith I; Szer J; Chapman JR
    Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA; Nagler A; Iannone R; Nelson RM
    Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.